The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization
出版年份 2014 全文链接
标题
The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 11, Pages e112159
出版商
Public Library of Science (PLoS)
发表日期
2014-11-12
DOI
10.1371/journal.pone.0112159
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Detection of ALK expression in non-small-cell lung cancer withALKgene rearrangements - comparison of multiple immunohistochemical methods
- (2014) Karen Zwaenepoel et al. HISTOPATHOLOGY
- Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project
- (2014) Fiona H. Blackhall et al. JOURNAL OF CLINICAL ONCOLOGY
- Higher Quality of Molecular Testing, an Unfulfilled Priority
- (2014) Lien Tembuyser et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances
- (2014) Florian Cabillic et al. Journal of Thoracic Oncology
- Prognostic and predictive biomarkers in lung cancer. A review
- (2014) Erik Thunnissen et al. VIRCHOWS ARCHIV
- Lung Cancer Biomarkers: Present Status and Future Developments
- (2013) Philip T. Cagle et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Molecular genetic testing for lung adenocarcinomas: a practical approach to clinically relevant mutations and translocations
- (2013) Sanja Dacic JOURNAL OF CLINICAL PATHOLOGY
- Improvement in the quality of molecular analysis ofEGFRin non-small-cell lung cancer detected by three rounds of external quality assessment
- (2013) Zandra C Deans et al. JOURNAL OF CLINICAL PATHOLOGY
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
- (2013) Neal I. Lindeman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Management of non-small-cell lung cancer: recent developments
- (2013) Martin Reck et al. LANCET
- On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
- (2013) Lénaïg Mescam-Mancini et al. LUNG CANCER
- Immunohistochemistry reliably detects ALK rearrangements in patients with advanced non-small-cell lung cancer
- (2013) Xiao-Hong Han et al. VIRCHOWS ARCHIV
- Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)
- (2012) Pilar Garrido et al. Clinical & Translational Oncology
- Variants on a Theme: A Biomarker of Crizotinib Response in ALK-Positive Non-Small Cell Lung Cancer?
- (2012) A. S. Crystal et al. CLINICAL CANCER RESEARCH
- Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
- (2012) J. M. Heuckmann et al. CLINICAL CANCER RESEARCH
- Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non–Small-Cell Lung Carcinoma and is Antibody Dependent
- (2012) Chris M.J. Conklin et al. Journal of Thoracic Oncology
- Guideline on the requirements of external quality assessment programs in molecular pathology
- (2012) J. Han van Krieken et al. VIRCHOWS ARCHIV
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
- (2012) Erik Thunnissen et al. VIRCHOWS ARCHIV
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New Strategies for Treatment of ALK-Rearranged Non-Small Cell Lung Cancers
- (2011) T. Sasaki et al. CLINICAL CANCER RESEARCH
- EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy
- (2011) E. Thunnissen et al. JOURNAL OF CLINICAL PATHOLOGY
- Bright-Field Dual-Color Chromogenic In Situ Hybridization for Diagnosing Echinoderm Microtubule-Associated Protein-Like 4-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinomas
- (2011) Akihiko Yoshida et al. Journal of Thoracic Oncology
- A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
- (2010) M. Mino-Kenudson et al. CLINICAL CANCER RESEARCH
- Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment
- (2010) D. R. Camidge et al. CLINICAL CANCER RESEARCH
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
- (2010) Josef Rüschoff et al. VIRCHOWS ARCHIV
- KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
- (2009) K. Takeuchi et al. CLINICAL CANCER RESEARCH
- Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non-Small Cell Lung Cancer
- (2008) Y. L. Choi et al. CANCER RESEARCH
- Gefitinib in Advanced Non-Small Cell Lung Cancer: Does It Deserve a Second Chance?
- (2008) T. E. Stinchcombe et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started